Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Autoimmune Diseases Clinical Trials

21 recruiting trials for Autoimmune Diseases. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
21
Total Trials
21
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06426316

The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.

Migraine is a frequent and debilitating neurologic disorder. It is more frequent in women, and more prevalent in patients with autoimmune and/or inflammatory diseases such as...

Sponsor: University Hospital, Clermont-FerrandEnrolling: 3961 location
RECRUITINGNCT04806620

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle information from...

Sponsor: Brain Inflammation CollaborativeEnrolling: 100001 location
RECRUITINGNCT07348432

The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes

Type 1 diabetes is an autoimmune health condition that requires daily injections of insulin. Insulin allows the body to use energy from carbohydrates in food. Disordered eating...

Sponsor: McGill UniversityEnrolling: 1061 location
RECRUITINGNCT06339957

Rheumatology Diet Study

This study aims to collect information on rheumatology patients' dietary habits, autoimmune disease activity, dietary changes, disease symptom improvements, and perceptions on...

Sponsor: University of Central FloridaEnrolling: 5001 location
RECRUITINGEarly Phase 1NCT07246096

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of...

A single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19/BCMA U CAR T cells in patients with autoimmune diseases. 60 patients are...

Sponsor: Changhai HospitalEnrolling: 601 location
RECRUITINGNCT05958446

Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women

Serological positivity for anti Ro-SSA antibodies is frequently found in pathologies such as Sjogren's Syndrome and SLE. Worldwide, approximately 0.5-1% of women of reproductive...

Sponsor: ASST Fatebenefratelli SaccoEnrolling: 2001 location
RECRUITINGNCT07121777

Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases

This is an open label, single-site, dose-escalation study in up to 18 participants with treatment of Refractory Autoimmune Diseases. This study aims to evaluate the safety and...

Sponsor: Anhui Provincial HospitalEnrolling: 181 location
RECRUITINGNCT07052565

CAR-T Cells Therapy for Patients With Autoimmune Diseases

This is an open label, single-site, dose-escalation study in up to 18 participants with refractory autoimmune diseases. This study aims to evaluate the safety and efficacy of the...

Sponsor: Anhui Provincial HospitalEnrolling: 181 location
RECRUITINGNCT06948110

Deciphering the Genetic Architecture of Autoimmune Diseases

Background: Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause these diseases have been well studied in people with...

Sponsor: National Human Genome Research Institute (NHGRI)Enrolling: 3002 locations
RECRUITINGNCT06587828

A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease

The most clinically meaningful way to discover new targets of T cells in autoimmune diseases is to study the tissues of patients with active autoimmune disease mediated organ...

Sponsor: TScan Therapeutics, Inc.Enrolling: 30012 locations
RECRUITINGPhase 1 / Phase 2NCT05565248

An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects...

This is an open-label, multicenter, Phase 1/2 study evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects with T1D

Sponsor: CRISPR Therapeutics AGEnrolling: 402 locations
RECRUITINGPhase 1 / Phase 2NCT06575426

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes...

This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tolerability, and...

Sponsor: Otsuka Pharmaceutical Factory, Inc.Enrolling: 131 location
RECRUITINGNCT07362654

Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease

This study investigates how the immune system of children with celiac disease responds to controlled, small amounts of gluten. Children on a strict gluten-free diet are randomly...

Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludEnrolling: 451 location
RECRUITINGPhase 1 / Phase 2NCT06350110

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

This study is a preliminary investigation, with a single-group design, not randomized and transparent, focusing on treatment. Its purpose is to identify the highest dose of BH002...

Sponsor: Essen BiotechEnrolling: 751 location
RECRUITINGPhase 1NCT07305116

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated autoimmune disease.

Sponsor: The Children's Hospital of Zhejiang University School of MedicineEnrolling: 151 location
RECRUITINGNCT03276923

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

This multi-site registry, centered at Duke University, will enroll pregnant women with autoimmune and rheumatologic diseases. The main goal of MADRA is to identify ways to...

Sponsor: Duke UniversityEnrolling: 10001 location
RECRUITINGPhase 1NCT06626919

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related...

A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia gravis (GMG)....

Sponsor: Arcellx, Inc.Enrolling: 3013 locations
RECRUITINGEarly Phase 1NCT04561557

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous...

Antibody-mediated inflammatory diseases of the nervous system (also known as autoimmune diseases of the nervous system) are autoimmune diseases in which autoimmune cells and...

Sponsor: Tongji HospitalEnrolling: 361 location
RECRUITINGNCT06502015

Biomarkers in Autoimmune Disease of Nervous System

Neurological autoimmune diseases are a group of disorders characterized by the abnormal immune response attacking the nervous system, including the brain, spinal cord and...

Sponsor: Tongji HospitalEnrolling: 500001 location
RECRUITINGNCT05383339

Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases

The objective of this work is to identify, in patients with autoimmune diseases, systemic vasculitis and autoinflammatory disease, cytokine and lymphocyte biomarkers of activity...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 22501 location
RECRUITINGNCT05678374

Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease

Mental fatigue occurs in many diseases and the reasons are mostly unknown. The investigators hypothesize that remaining mental fatigue after restored hyperthyroidism in Graves'...

Sponsor: Vastra Gotaland RegionEnrolling: 1801 location